Skip to main content
SpringerLink
Log in

Enzyme Contents of Pancreatic Extract Preparations

Are They Optimal?

  • Leading Article
  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • Abrams CK, Hamosh M, Hubbard VS, Dutta SK, Hamosh P. Lingual lipase in cystic fibrosis. Quantitation of enzyme activity in the upper small intestine of patients with exocrine pancreatic insufficiency. Journal of Clinical Investigation 73: 374–382, 1984

    Article  PubMed  CAS  Google Scholar 

  • Atkinson SN. A comparative study of the enzyme activity, acid resistance and dissolution characteristics of four enteric coated microsphere preparations of pancreatin. European Journal of Clinical Research 1: 37–45, 1991

    Google Scholar 

  • Beverley DW, Kelleher J, Macdonald A, Littlewood JM, Robinson T, et al. Comparison of four pancreatic extracts in cystic fibrosis. Archives of Disease in Childhood 62: 564–568, 1987

    Article  PubMed  CAS  Google Scholar 

  • Cleghorn GJ, Shepherd RW, Holt TL. The use of a synthetic prostaglandin E1 analogue (Misoprostol) as an adjunct to pancreatic enzyrne replacement in cystic fibrosis. Scandinavian Journal of Gastroenterology 23 (Suppl. 143): 142–147, 1988

    Article  Google Scholar 

  • Colombo C, Arlati S, Curcio L, Malvacca R, Garatti M, et al. Effect of taurine supplementation on fat and bile acid absorption in patients with cystic fibrosis. Scandinavian Journal of Gastroenterology 23 (Suppl. 143): 125–131, 1988

    Article  Google Scholar 

  • DiMagno EP. Patterns of human exocrine pancreatic secretion and fate of human pancreatic enzymes during aboral transit. In PG Lankirsch (Ed.) Pancreatic enzymes in health and disease, pp. 1–10, Springer-Verlag, 1991

    Chapter  Google Scholar 

  • DiMagno EP, Go ULW, Summerskill WHJ. Relations between pancreatic enzyme outputs and malabsorbtion-in severe pancreatic insufficiency. New England Journal of Medicine 288: 813–815, 1973

    Article  PubMed  CAS  Google Scholar 

  • DiMagno EP, Malagelada JR, Go ULW, Moertel CG. Fate of orally ingested enzymes in pancreatic insufficiency. New England Journal of Medicine 296: 1318–1322, 1977

    Article  PubMed  CAS  Google Scholar 

  • Durie PA, Bell L, Linton W, Corey M, Forstner GG. Effect of cimetidine and sodium bicarbonate on pancreatic replacement therapy in cystic fibrosis. Gut 21: 778–786, 1980

    Article  PubMed  CAS  Google Scholar 

  • Elliott RB, Escobar LC, Lees HR, Akroyd MD, Reilly HC. A comparison of two pancreatic microsphere preparations in cystic fibrosis. New Zealand Medical Journal 105: 107–108, 1992

    PubMed  CAS  Google Scholar 

  • Gaskin KJ. The impact of nutrition on cystic fibrosis: a review. Journal of Pediatric Gastroenterology and Nutrition 7 (Suppl. 1): S12–S17, 1988

    Article  PubMed  Google Scholar 

  • Gaskin KJ, Durie PR, Hill RE, Lee LM, Forstner GG. Colipase and maximally activated pancreatic lipase in normal subjects and in patients with steatorrhoea. Journal of Clinical Investigation 69: 427–434, 1982a

    Article  PubMed  CAS  Google Scholar 

  • Gaskin K, Gurwitz D, Durie P, Corey M, Levison H, et al. Improved respiratory prognosis in patients with cystic fibrosis and normal fat absorption. Journal of Pediatrics 100: 857–862, 1982b

    Article  PubMed  CAS  Google Scholar 

  • George DE, Mangos JA. Nutritional management and pancreatic enzyme therapy in cystic fibrosis patients: state of the art in 1987 and projections into the future. Journal of Pediatric Gastroenterology and Nutrition 7 (Suppl. 1): S49–S57, 1988

    Article  PubMed  Google Scholar 

  • George DE, Pinero R, Miller AB, Toskes PP, Sitren HS, et al. Comparison of two pancreatic enzyme supplements in patients with cystic fibrosis. Advances in Therapy 7: 109–118, 1990

    Google Scholar 

  • Goodchild MC, Murphy GM, Howell AM, Nutter SA, Anderson CM. Aspects of bile acid metabolism in cystic fibrosis. Archives of Disease in Childhood 50: 769–778, 1975

    Article  PubMed  CAS  Google Scholar 

  • Goodchild MC, Sagaro E, Brown GA, Cruchley PM, Jukes HR, et al. Comparative trial of Pancrex V forte and Nutrizym in the treatment of malabsorption in cystic fibrosis. British Medical Journal II: 712–714, 1974

    Article  Google Scholar 

  • Graham DY. Enzyme replacement therapy of exocrine pancreatic insufficiency in Man. Relation between in vitro enzyme activities and in vivo potency in commercial pancreatic extracts. New England Journal of Medicine 296: 1314–1317, 1977

    Article  PubMed  CAS  Google Scholar 

  • Graham DY. Pancreatic enzyme replacement: the effect of antacids or cimetidine. Digestive Diseases and Sciences 27: 485–490, 1982

    Article  PubMed  CAS  Google Scholar 

  • Gow R, Bradbear R, Francis P, Shepherd R. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea: effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Lancet 2: 1071–1074, 1981

    Article  PubMed  CAS  Google Scholar 

  • Hadorn B, Johansen PG, Anderson CM. Pancreozymin-secretin test of exocrine pancreatic function in cystic fibrosis and significance of the result for the pathogenesis of the disease. Canadian Medical Association Journal 98: 377–385, 1968

    PubMed  CAS  Google Scholar 

  • Jonas A, Diver-Haber A. Bile acid sequestration by the solid phase of stools in cystic fibrosis patients: role of pancreatic enzymes. Digestive Diseases and Sciences 33: 724–731, 1988

    Article  PubMed  CAS  Google Scholar 

  • Littlewood JM, Kelleher J, Walters MP, Johnson AW. In vivo and in vitro studies of microsphere pancreatic supplements. Journal of Pediatric Gastroenterology and Nutrition 7 (Suppl. I): S22–S29, 1988

    Article  PubMed  Google Scholar 

  • Morrison G, Morrison J, Redmond J, Byers C, McCracken K, et al. Pancreatic enzyme supplements in cystic fibrosis. Correspondence. Lancet 2: 1596–1597, 1991

    Article  Google Scholar 

  • O’Rawe A, McIntosh I, Dodge JA, Brock DJH, Redmond AOB, et al. Increased energy expenditure in cystic fibrosis is associated with specific mutations. Clinical Science 82: 71–76, 1992

    PubMed  Google Scholar 

  • Pap A, Varro V. Replacement therapy in pancreatic insufficiency with a new pancreatic preparation respecting the physiological ratio of lipase/trypsin activity. Hepato-Gastroenterology 35: 83–86, 1988

    PubMed  CAS  Google Scholar 

  • Robinson PJ, Smith AL, Sly PD. Duodenal pH in cystic fibrosis and its relationship to fat malabsorption. Digestive Diseases and Sciences 35: 1299–1304, 1990

    Article  PubMed  CAS  Google Scholar 

  • Roy CC, Weber AM, Lepage G, Smith L, Levy E. Digestive and absorptive phase anomalies associated with exocrine pancreatic insufficientcy of cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition 7 (Suppl. 1): S1–S7, 1988

    Article  PubMed  Google Scholar 

  • Roy CC, Weber AM, Morin CL, Coobes JC, Nussle D, et al. Abnormal biliary lipid composition in cystic fibrosis. Effect of pancreatic enzymes. New England Journal of Medicine 297: 1301–1305, 1977

    Article  PubMed  CAS  Google Scholar 

  • Sack J, Blau H, Goldfarb D, Ben-Zaray S, Katnelson D. Hyperuricosuria in cystic fibrosis patients treated with pancreatic enzyme supplements. Israel Journal of Medical Sciences 16: 417–419, 1980

    PubMed  CAS  Google Scholar 

  • Stead RJ, Skypala I, Hodson ME, Batten JC. Enteric coated microspheres of pancreatin in treatment of cystic fibrosis: comparison with a standard enteric coated prepatation. Thorax 42: 533–537, 1987

    Article  PubMed  CAS  Google Scholar 

  • Watkins JB, Tercyak AM, Szczepanik P, Klein PD. Bile acid kinetics in cystic fibrosis: influence of pancreatic enzyme replacement. Gastroenterology 73: 1023–1028, 1977

    PubMed  CAS  Google Scholar 

  • Weber A, Roy CC, Morin CL, Lasalle R. Malabsorbtion of bile acids in children with cystic fibrosis. New England Journal of Medicine 289: 1001–1005, 1973

    Article  PubMed  CAS  Google Scholar 

  • Whitehead AM. Study to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations. Pharmaceutisch Weekblad Scientific Edition 10: 12–16, 1988

    Article  PubMed  CAS  Google Scholar 

  • Williams J, MacDonald A, Weller PH, Fields J, Pandov H. Two enteric coated microspheres in cystic fibrosis. Archives of Disease in Childhood 65: 594–597, 1990

    Article  PubMed  CAS  Google Scholar 

  • Zentler-Munro PL. Cystic fibrosis — a gastroenterological cornucopia. Gut 28: 1531–1547, 1987

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Child Health, Royal Gwent Hospital, Newport, Gwent, NP9 2UB, Wales

    Sabine Maguire

  2. Cystic Fibrosis Unit, Department of Child Health, University Hospital of Wales, Cardiff, Wales

    Mary C. Goodchild

Authors
  1. Sabine Maguire
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mary C. Goodchild
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Maguire, S., Goodchild, M.C. Enzyme Contents of Pancreatic Extract Preparations. Drugs 44, 685–689 (1992). https://doi.org/10.2165/00003495-199244050-00001

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199244050-00001

Keywords

Search

Navigation